Myocardial Mycn is essential for mouse ventricular wall morphogenesis

Area of Science:

• Cardiovascular Development
• Molecular Biology
• Developmental Genetics

Background:

• MYCN is a transcription factor implicated in development and disease, including Feingold syndrome with congenital heart defects.
• The specific role of MYCN in cardiac development is not well understood.
• Mouse models are essential for studying gene function in developmental processes.

Purpose of the Study:

• To investigate the cardiac-specific functions of MYCN during mouse heart development.
• To elucidate the molecular mechanisms by which MYCN influences myocardial morphogenesis.
• To determine the relationship between MYCN and BMP/NRG1 signaling in cardiogenesis.

Main Methods:

• Utilized a Cre/loxp genetic strategy for conditional deletion of Mycn in the developing mouse myocardium.
• Analyzed cardiac morphology and cellular phenotypes in Mycn-deficient embryos.
• Investigated gene expression related to cell cycle, growth, and sarcomere formation.

Main Results:

• Myocardial deletion of Mycn led to thin myocardial walls and reduced trabeculation, mimicking BMP10 and Neuregulin-1 (NRG1) pathway disruptions.
• MYCN expression is regulated by BMP and NRG1 signaling.
• Reduced cardiomyocyte proliferation and cell size were observed in Mycn-mutant hearts.
• MYCN regulates cell cycle genes (CCND1, CCND2, ID2) and growth pathways (p70S6K).
• Mycn inactivation altered sarcomere protein expression, affecting cardiomyocyte differentiation.

Conclusions:

• Mycn acts downstream of BMP and NRG1 signaling pathways in promoting normal myocardial wall development.
• MYCN is essential for regulating cardiomyocyte proliferation, growth, and differentiation during heart development.
• These findings highlight MYCN's critical role in cardiac morphogenesis.